Facility Information

SHANGHAI, CHINA
WORLDWIDE MEDICINES
(Sino-American Shanghai Squibb Pharmaceuticals Ltd., (SASS))

Facts and Figures

The SASS Facility is located in the Minghang district of Shanghai, covering 58,000 square meters with total floor space of 37,000 square meters.
The Shanghai facility is a pharmaceutical plant that manufactures:
- Antibiotics
- Cardiovascular
- Multi-vitamin Supplements
- Analgesics
- Metabolics

Topicals

Recent construction or expansion:
- 2004: A new expansion project of 1,080 square meters for production of Entecavir was completed.
- 2005: About 1,200 square meters expansion for Non-Lactam and QC lab was finished.
- 2006: Re-construction of part of existing QC Lab will be started at the end of the year.

Economic Development

Capital investment:
- 2004: US$3.8 million
- 2005: US$5 million
Contribution to tax base:
- approximately US$2.1 million annually
Contribution to local economy from wages and benefits:
- approximately US$9.7 million annually
Local charitable contributions in 2005:
- Adopted a China tiger that is ranked the number one endangered species worldwide by donating US$12,500.
- Supported project "Charity Medical Card" by providing six million RMB worth of medicines in three years to the designated 285 hospitals and community hygiene centers to help some poor residents who have not been covered by the municipal medical issuance system to obtain basic charity medical aid.
- Donated 3000,000 RMB worth of Theragran JR to the poor pupils in the Shanghai area and DaYingBAng primary school in Yuexi county of Sichuan LiangZhou Yi, autonomous prefecture aimed at improving the health of children.
- Contributed $50,000 to The China Foundation for Hepatitis Prevention and Control (CFHPC) on the project of "Analysis of current hepatitis spreading situation and related issues in China"

Community and Social Progress

The facility's employee safety record reflects that there were no lost time incidents in 2005.

Civic Activities:

Rebuilt a road in the community and beautified the two sides along the road with total investment of US$37,000.
Evidence-based medical seminar to brief doctors of the latest clinic research and treatment practices.
Live broadcasting of latest clinic research results through satellite to doctors in 20 cities.
Education campaigns on chronic and common diseases in collaboration with major media in various provinces.
Gold Theragran Vitamin nutrition and health education campaign in 26 cities.
Children health education campaign in Shanghai to promote health awareness among children in the city by children-friendly activities.
Bufferin Drug Box program to promote OTC self-medication knowledge.

Awards and recognition:

Safety Leadership Award in 2005
Safety Excellence Plaque in 2004
SASS has received the following honors given by the government:

High Technology Enterprise
Model Enterprise
Best Image Enterprises in Shanghai
Top 10 Pharmaceutical Joint-Ventures in China

Practices using local products and services:

SASS developed more than 60 vendors inside China, some of which are able to provide their products worldwide.
SASS purchased approximately US$21.8 million worth of goods in China annually since 1999.

Environmental Performance

SASS management has set several aggressive goals in these areas:

Continuously improve EHS awareness of all employees on site, as well as contractors. Educating employees on EHS will improve performance all around.
Achieve the "Three Zeros:" Zero fire, zero professional-related diseases, and zero professional-related injuries.
The Shanghai facility plans to be an EHS leader in China's pharmaceutical industry by integrating EHS into all business phases and creating an accident-free work environment.
The SASS facility continues to be an industry leader in ISO 14001 compliance.
Pollution Prevention through Product Life Analysis yielded a 320 ton reduction of cardboard which saved an equivalent of 1,900 trees from 1997 to 2004.

Safety performance highlights:

In SASS, EHS training is incorporated into the orientation program for employees new to the site and for employee rotation. This training covers the company's commitment to safety and environmental protection.
As a standard practice, SASS conducts safety evaluation prior to purchasing a new machine or designing a new project and conducts a comprehensive inspection including GMP and EHS. As such, most hardware-associated hazards were eliminated at the design phase.
As a result of the above best practice, SASS made measurable progress towards creating an accident-free work site.

Key Facility Environmental Performance Metrics 2005
Total energy use	237,658 gigajoules
Water use	172,700,567 liters
Nonhazardous waste disposed	0 kilograms*
Hazardous waste off-site treatment/disposal	119,420 kilograms

* Shanghai recycles most nonhazardous waste.

Facility Contact Information

+ 86-21-6430-2740

(see also Bristol-Myers Squibb China)

Last updated October 27, 2006 . Italicized product names are registered trademarks of Bristol-Myers Squibb Company or one of its divisions or subsidiaries. Copyright © 1998-2006 Bristol-Myers Squibb Company. Your use of the information on this site is subject to the terms of our Legal Notices.

Facility Information:

Facts and Figures

Economic Development

Community and Social Progress

Environmental Performance

Facility Contact Information

Return to List of Facilities